Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 May;79(1):225-31.
doi: 10.1111/j.1476-5381.1983.tb10516.x.

Direct inhibitory effects of some 'calcium-antagonists' and trifluoperazine on the contractile proteins in smooth muscle

Direct inhibitory effects of some 'calcium-antagonists' and trifluoperazine on the contractile proteins in smooth muscle

M Spedding. Br J Pharmacol. 1983 May.

Abstract

1 Taenia preparations from the guinea-pig caecum were treated with Triton X-100 and glycerol to disrupt the plasma membrane. Disruption of the sarcolemma was confirmed by electronmicroscopy. The preparations contracted in response to low concentration of Ca2+ (10-40 microM) and the contractions were dependent upon exogenous adenosine triphosphate (ATP). 2 Nifedipine (100 microM), verapamil (100 microM) and diltiazem (100 microM) did not inhibit Ca2+-induced activation of the contractile proteins. 3 In contrast, fendiline (100 microM), cinnarizine (100 microM), flunarizine (100 microM), pimozide (100 microM) and trifluoperazine (100 microM) significantly inhibited Ca2+-induced contractions. The effects of cinnarizine (100 microM) were reversible. 4 These findings disclose further differences between calcium-antagonists and suggest that certain of these agents have an intracellular site of action.

PubMed Disclaimer

References

    1. Br J Pharmacol. 1969 Jul;36(3):549-60 - PubMed
    1. Annu Rev Pharmacol Toxicol. 1977;17:149-66 - PubMed
    1. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3527-30 - PubMed
    1. Eur J Pharmacol. 1978 Dec 15;53(1):113-6 - PubMed
    1. Eur J Pharmacol. 1979 Feb 15;54(1-2):79-91 - PubMed

LinkOut - more resources